Market Overview:
The global direct-to-consumer laboratory testing market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing demand for routine clinical laboratory testing and medical genetic laboratory testing, rising awareness about personal health, and growing number of online diagnostic service providers. However, the high cost of tests and lack of reimbursement are some factors that may restrain the growth of this market during the forecast period. Based on type, the global direct-to-consumer laboratory testing market is segmented into routine clinical laboratory testing and medical genetic laboratory testing. Routine clinical laboratory tests are further subsegmented into chemistry tests, hematology tests, immunology & serology tests, microbiology & virology tests, and toxicology & drug screening testes; while medical genetic labortatorytests are further subsegmented into chromosomal analysis testes (karyotyping), DNA sequencing testes (genetic sequencing), gene expression profiling testes (gene expression profiling), mutation detection assaytestes (mutation detection assay), single nucleotide polymorphism identificationteste(single nucleotide polymorphism identification)and others).
Product Definition:
Direct-to-Consumer Laboratory Testing is a term used to describe the growing trend of individuals ordering laboratory tests directly from commercial laboratories. The importance of Direct-to-Consumer Laboratory Testing lies in the fact that it allows consumers to have more control over their health care and provides them with information about their own health. Additionally, Direct-to-Consumer Laboratory Testing can help identify potential health risks and allow for earlier treatment.
Routine Clinical Laboratory Testing:
Routine clinical laboratory testing is a category of tests that are done on a routine basis in hospitals and clinics. These tests include blood gas & electrolyte analysis, complete blood count, basic metabolic panel, comprehensive metabolic panel (CMP), thyroid-stimulating hormone (TSH), urine test for ketone and leukocyte esters, urinalysis including nitrate/nitrite measurement if applicable along with coagulation factors.
Medical Genetic Laboratory Testing:
Medical Genetic Laboratory Testing is used for the analysis of inherited, infectious and common diseases. It also analyzes the genetic component of various cancers and other disorders. Medical Genetic Laboratories (MGL) provide testing services to both healthcare professionals as well as consumers in order to advance preventive care.
Application Insights:
The others application segment includes environmental testing, food safety and quality testing, and product safety & security testing. The other applications are expected to witness the fastest growth owing to rising demand for consumer goods along with technological advancements in various fields such as agriculture, nutrition & dietetics, forensics, and pharmaceuticals.
Health application dominated the market in 2017 due to factors such as increasing prevalence of chronic diseases that require regular monitoring by healthcare professionals coupled with a growing preference for self-monitoring at home through DTC laboratories. Moreover, an increase in number of direct-to-consumer healthcare advertisements by various companies is also likely to contribute towards segment growth over the forecast period.
Rising prevalence of cancer is one of the major drivers leading towards increased demand for DTC lab tests across all applications segments.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of direct-to-consumer testing companies, such as 23andMe Inc.; deCODEme LLC; and Navigenics, Inc., in this region. These companies offer genetic tests for various diseases and conditions. Moreover, these companies have been making huge investments for research on human genome that is affecting health across the world. Such developments are expected to fuel regional growth over the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to growing penetration of direct-to-consumer (DTC) laboratories offering DTC genetic tests coupled with an increase in awareness about these services among people living in this region as compared to other regions globally. Furthermore, government initiatives encouraging population screening programs are also anticipated boost regional growth over next eight years (from 2018 to 2030).
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of chronic diseases
- Technological advancements in laboratory testing
- Growing awareness about the benefits of early diagnosis and treatment
- Proliferation of private healthcare sector
Scope Of The Report
Report Attributes
Report Details
Report Title
Direct-to-Consumer Laboratory Testing Market Research Report
By Type
Routine Clinical Laboratory Testing, Medical Genetic Laboratory Testing
By Application
Health, Genetic, Others
By Companies
Quest Diagnostics, LabCorp, 23 and Me, Any Lab Test Now, Color Genomics, Pathway Genomics, Konica Minolta, Myriad Genetics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Direct-to-Consumer Laboratory Testing Market Report Segments:
The global Direct-to-Consumer Laboratory Testing market is segmented on the basis of:
Types
Routine Clinical Laboratory Testing, Medical Genetic Laboratory Testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Health, Genetic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Quest Diagnostics
- LabCorp
- 23 and Me
- Any Lab Test Now
- Color Genomics
- Pathway Genomics
- Konica Minolta
- Myriad Genetics
Highlights of The Direct-to-Consumer Laboratory Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Routine Clinical Laboratory Testing
- Medical Genetic Laboratory Testing
- By Application:
- Health
- Genetic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Direct-to-Consumer Laboratory Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Direct-to-consumer laboratory testing is a type of medical testing that allows consumers to have their own blood or urine tested for specific diseases. This type of testing is typically done by private laboratories, rather than by the government or major health care providers.
Some of the major companies in the direct-to-consumer laboratory testing market are Quest Diagnostics, LabCorp, 23 and Me, Any Lab Test Now, Color Genomics, Pathway Genomics, Konica Minolta, Myriad Genetics.
The direct-to-consumer laboratory testing market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Direct-to-Consumer Laboratory Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Direct-to-Consumer Laboratory Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Direct-to-Consumer Laboratory Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Direct-to-Consumer Laboratory Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Direct-to-Consumer Laboratory Testing Market Size & Forecast, 2018-2028
4.5.1 Direct-to-Consumer Laboratory Testing Market Size and Y-o-Y Growth
4.5.2 Direct-to-Consumer Laboratory Testing Market Absolute $ Opportunity
Chapter 5 Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Direct-to-Consumer Laboratory Testing Market Size Forecast by Type
5.2.1 Routine Clinical Laboratory Testing
5.2.2 Medical Genetic Laboratory Testing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Direct-to-Consumer Laboratory Testing Market Size Forecast by Applications
6.2.1 Health
6.2.2 Genetic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Direct-to-Consumer Laboratory Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Direct-to-Consumer Laboratory Testing Analysis and Forecast
9.1 Introduction
9.2 North America Direct-to-Consumer Laboratory Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Direct-to-Consumer Laboratory Testing Market Size Forecast by Type
9.6.1 Routine Clinical Laboratory Testing
9.6.2 Medical Genetic Laboratory Testing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Direct-to-Consumer Laboratory Testing Market Size Forecast by Applications
9.10.1 Health
9.10.2 Genetic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Direct-to-Consumer Laboratory Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Direct-to-Consumer Laboratory Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Direct-to-Consumer Laboratory Testing Market Size Forecast by Type
10.6.1 Routine Clinical Laboratory Testing
10.6.2 Medical Genetic Laboratory Testing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Direct-to-Consumer Laboratory Testing Market Size Forecast by Applications
10.10.1 Health
10.10.2 Genetic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Direct-to-Consumer Laboratory Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Direct-to-Consumer Laboratory Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Direct-to-Consumer Laboratory Testing Market Size Forecast by Type
11.6.1 Routine Clinical Laboratory Testing
11.6.2 Medical Genetic Laboratory Testing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Direct-to-Consumer Laboratory Testing Market Size Forecast by Applications
11.10.1 Health
11.10.2 Genetic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Direct-to-Consumer Laboratory Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Direct-to-Consumer Laboratory Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Direct-to-Consumer Laboratory Testing Market Size Forecast by Type
12.6.1 Routine Clinical Laboratory Testing
12.6.2 Medical Genetic Laboratory Testing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Direct-to-Consumer Laboratory Testing Market Size Forecast by Applications
12.10.1 Health
12.10.2 Genetic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Direct-to-Consumer Laboratory Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Direct-to-Consumer Laboratory Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Direct-to-Consumer Laboratory Testing Market Size Forecast by Type
13.6.1 Routine Clinical Laboratory Testing
13.6.2 Medical Genetic Laboratory Testing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Direct-to-Consumer Laboratory Testing Market Size Forecast by Applications
13.10.1 Health
13.10.2 Genetic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Direct-to-Consumer Laboratory Testing Market: Competitive Dashboard
14.2 Global Direct-to-Consumer Laboratory Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Quest Diagnostics
14.3.2 LabCorp
14.3.3 23 and Me
14.3.4 Any Lab Test Now
14.3.5 Color Genomics
14.3.6 Pathway Genomics
14.3.7 Konica Minolta
14.3.8 Myriad Genetics
